top of page
Using credibility, creativity and competence to forge a seamless link between New Zealanders and the best medicines in the world.
A ONE-STOP SHOP FOR THE PHARMACEUTICAL INDUSTRY
WHY
The NZ Pharmaceutical market is challenging. A single-payer model working to provide the best possible value for New Zealanders by putting a value on access.
Pharmaceutical companies over the past 20 years have found this difficult to constantly scale up or down depending on the products they have funded.
We are here to remove this challenge and manage your NZ interests for you.
“Eisai New Zealand worked with Nick Leach in 2022 as our organization wanted some experienced insights to progress proposals to PHARMAC for the funding of Eisai medicines. Nick helped us to increase our understanding of the NZ environment and tailor our proposals in a way that helped us advance our negotiations significantly. Nick brings a solid understanding of the New Zealand funding environment and is responsive and aligned to the Eisai patient centric approach. We wish Wellmed.NZ success in broadening access to medicines for NZ patients.”
John Bower
Medical Director and Head of Market Access, Australia and New Zealand
Articles
bottom of page